https://orcid.org/0000-0001-6837-9895
Dear editor
We appreciate Sun et al for their interest and comments about our recent paperCitation1 in Clinical Interventions in Ageing regarding a relationship between thyroid hormone sensitivity and mild cognitive impairment (MCI) in euthyroid patients with type 2 diabetes (T2D). In terms of the exclusion criteria, Sun et al raised four points to be clarified or discussed, and we appreciate the opportunity to provide supplementary insights.
The first point concerns the lack of vitamin D data. We agree that vitamin D levels are generally low in the Chinese population with T2D and that reduced vitamin D concentrations may be associated with cognitive impairment. However, recent large-scale population studies have yielded conflicting results, indicating that vitamin D status may not be significantly associated with cognitive function.Citation2,Citation3 Given the existing contradictions in the current findings, it may be premature to definitively conclude that vitamin D plays a pivotal role in cognitive function. Furthermore, we observed that the previously published literature on cognitive impairment related to T2DCitation4,Citation5 or the association between thyroid function and cognitive functionCitation6,Citation7 did not exclude individuals with vitamin D deficiency. Therefore, it is plausible that vitamin D deficiency may not be an obligatory exclusion criterion.
The second point is about the lack of data on bone mineral density (BMD) and bone turn over markers (BTMS). While we acknowledge the potential link between bone loss, osteoporosis, and cognitive impairment, it is noteworthy that there exists no consensus within the literature on this subject.Citation8 Moreover, it appears that bone loss and osteoporosis are not established as recognized exclusion criteria in studies of cognitive impairment related to T2DCitation4,Citation5 or in studies examining the association between thyroid function and cognitive function.Citation6,Citation7
The third point pertains to the lack of nutrition status data. We concur that major diseases, such as poor nutritional status, cancer, and severe liver or renal dysfunction, are closely related to cognitive impairment. Consequently, we excluded patients with these aforementioned conditions.
The fourth point regards the lack of estimated glomerular filtration rate (eGFR) data. First, as mentioned above, we have excluded patients with severe renal dysfunction. Secondly, it is regrettable that we did not collect eGFR data; however, we did obtain creatinine, which is another crucial indicator for assessing renal function. Our findings showed no significant difference in creatinine between the normal cognitive function group and the MCI group.
In conclusion, as confirmed by our study,Citation1 impaired sensitivity to thyroid hormones is associated with MCI in euthyroid patients with T2D. We actively recommend thyroid function examination for the early identification of MCI in patients with T2D. It’s crucial to emphasize that the focus on thyroid function should not solely revolve around single hormone alterations but should also encompass a consideration of thyroid hormone sensitivity.
Disclosure
The authors report no conflicts of interest in this communication.
References
- Yu ZW, Pu SD, Sun XT, Wang XC, Gao XY, Shan ZY. Impaired sensitivity to thyroid hormones is associated with mild cognitive impairment in euthyroid patients with type 2 diabetes. Clin Interv Aging. 2023;18:1263–1274. doi:10.2147/CIA.S413584
- Barmaki O, Mansour A, Moodi M, et al. Serum vitamin D status and cognitive function in Iranian older adults: evidence from the Birjand Longitudinal Aging Study. J Nutr. 2023;153(8):2312–2319. doi:10.1016/j.tjnut.2023.06.033
- Lee DH, Chon J, Kim Y, et al. Association between vitamin D deficiency and cognitive function in the elderly Korean population: a Korean frailty and aging cohort study. Medicine. 2020;99(8):e19293. doi:10.1097/MD.0000000000019293
- Zheng T, Qin L, Chen B, et al. Association of plasma DPP4 activity with mild cognitive impairment in elderly patients with type 2 diabetes: results from the GDMD Study in China. Diabetes Care. 2016;39(9):1594–1601. doi:10.2337/dc16-0316
- Zhang Z, Zhang B, Wang X, et al. Olfactory dysfunction mediates adiposity in cognitive impairment of type 2 diabetes: insights from Clinical and Functional Neuroimaging Studies. Diabetes Care. 2019;42(7):1274–1283. doi:10.2337/dc18-2584
- Szlejf C, Suemoto CK, Santos IS, et al. Thyrotropin level and cognitive performance: baseline results from the ELSA-Brasil Study. Psychoneuroendocrinology. 2018;87:152–158. doi:10.1016/j.psyneuen.2017.10.017
- Zhang H, Yang S, Zhu W, et al. Free triiodothyronine levels are related to executive function and scene memory in type 2 diabetes mellitus patients without diagnosed thyroid diseases. Diabetes Metab Syndr Obes. 2022;15:1041–1050. doi:10.2147/DMSO.S355656
- Patel A, Jameson KA, Edwards MH, et al. Mild cognitive impairment is associated with poor physical function but not bone structure or density in late adulthood: findings from the Hertfordshire cohort study. Arch Osteoporos. 2018;13(1):44. doi:10.1007/s11657-018-0455-3